THNK Stock Overview Think Research Corporation provides knowledge-based digital health software solutions in Canada, the United States, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Think Research Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Think Research Historical stock prices Current Share Price CA$0.31 52 Week High CA$0.43 52 Week Low CA$0.15 Beta 0.76 1 Month Change -1.59% 3 Month Change 34.78% 1 Year Change -26.19% 3 Year Change -91.27% 5 Year Change n/a Change since IPO -93.67%
Recent News & Updates Healwell AI Inc. (TSX:AIDX) completed the acquisition of Bio Pharma Services Inc. from Think Research Corporation for CAD 15 million. Jul 03
Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million. Jun 15
Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million. Jun 14
Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 17.57 million. Apr 20
Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 17.57 million. Apr 19
Think Research Corporation, Annual General Meeting, Apr 04, 2024 Feb 21 See more updates Healwell AI Inc. (TSX:AIDX) completed the acquisition of Bio Pharma Services Inc. from Think Research Corporation for CAD 15 million. Jul 03
Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million. Jun 15
Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million. Jun 14
Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 17.57 million. Apr 20
Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 17.57 million. Apr 19
Think Research Corporation, Annual General Meeting, Apr 04, 2024 Feb 21
Beedie Capital entered into an arrangement agreement to acquire remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 25.58 million. Feb 18 Beedie Capital entered into an arrangement agreement to acquire remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 25.58 million. Feb 17
Is Think Research (CVE:THNK) Using Debt In A Risky Way? Feb 10
New major risk - Market cap size Feb 10
Insufficient new directors Feb 01
New major risk - Share price stability Jan 24
Little Excitement Around Think Research Corporation's (CVE:THNK) Revenues As Shares Take 28% Pounding Dec 18
New major risk - Market cap size Dec 07
New minor risk - Share price stability Dec 02
Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Nov 28
Think Research Corporation to Report Q3, 2023 Results on Nov 27, 2023 Nov 23
Think Research Corporation Appoints Jeffrey Orridge to Its Board of Directors Oct 21
Why Investors Shouldn't Be Surprised By Think Research Corporation's (CVE:THNK) 26% Share Price Plunge Sep 06
Price target decreased by 14% to CA$0.73 Sep 01
Second quarter 2023 earnings: EPS exceeds analyst expectations Aug 31
Think Research Corporation to Report Q2, 2023 Results on Aug 29, 2023 Aug 24
Think Research Corporation Announces Bridge Loan Aug 18
First quarter 2023 earnings released: CA$0.047 loss per share (vs CA$0.11 loss in 1Q 2022) May 31
Think Research Corporation, Annual General Meeting, Aug 11, 2023 May 27
Think Research Corporation to Report Q1, 2023 Results on May 29, 2023 May 25
Consensus EPS estimates fall by 17% May 08
Full year 2022 earnings: EPS misses analyst expectations May 01
Think Research Corporation (CVE:THNK) Shares Could Be 48% Below Their Intrinsic Value Estimate Feb 28
Analysts Have Been Trimming Their Think Research Corporation (CVE:THNK) Price Target After Its Latest Report Dec 01
Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Nov 30
Think Research Corporation to Report Q3, 2022 Results on Nov 28, 2022 Nov 26
High number of new directors Nov 16 Think Research Appoints John Hayes as Permanent Chief Financial Officer
Consensus revenue estimates fall by 11% Sep 05
Price target decreased to CA$1.25 Aug 30
Second quarter 2022 earnings: EPS and revenues miss analyst expectations Aug 29
Think Research Corporation to Report Q2, 2022 Results on Aug 29, 2022 Aug 25
Consensus forecasts updated Jun 06
Think Research Corporation, Annual General Meeting, Aug 02, 2022 May 28
Think Research Corporation to Report Q1, 2022 Results on May 30, 2022 May 27
Now 26% undervalued after recent price drop May 26
Now 24% undervalued after recent price drop May 10
Full year 2021 earnings: EPS and revenues miss analyst expectations May 03
High number of new directors Apr 27 Think Research Corporation announced that it expects to receive CAD 25 million in funding from Beedie Capital Apr 26
Price target decreased to CA$3.08 Apr 18
Think Research Corporation Announces Executive Changes Apr 07
Think Research Launches Electronic Data Capture System for its Clinical Research Phase 1 Business, Bio Pharma Services Inc Mar 30
Think Research Corporation Attests to Vendor Verification for Virtual Care in Ontario Jan 12
CEO & Director recently sold CA$86k worth of stock Dec 27
Consensus forecasts updated Nov 30
High number of new directors Nov 02
Chief Operating Officer Riyaz Lalani has left the company Oct 05 Think Research Corporation (TSXV:THNK) completed the acquisition of BioPharma Services Inc. from Mahy Investments Ltd., Moske Investments Ltd., N & M Medical Enterprises Inc., Ola Kassim Medicine Professional Corporation and Kashima International Inc. for CAD 43.3 million.
Consensus revenue estimates increase to CA$45.4m Jul 18
Think Research Corporation (TSXV:THNK) entered into a definitive agreement to acquire BioPharma Services Inc. for CAD 44.6 million. Jul 16
Think Research Corporation Sees 140% Year-Over-Year Growth for eForms Electronic Data Capture Software in U.S. Post-Acute Care Market Jun 23
Think Research Corporation Provides Earnings Guidance for the First Quarter Ended March 31, 2021 Apr 29
Analysts Expect Breakeven For Think Research Corporation (CVE:THNK) Before Long Mar 30
Think Research Partners with Carerx to Deliver Virtualcare Telemedicine Software in Retirement Homes Across Canada Mar 04
CareRx Corporation and Think Research Corporation Announces Their Canada-Wide Partnership to Deliver Virtual Healthcare to Seniors Mar 03
Full year 2020 earnings released: CA$0.40 loss per share (vs CA$0.59 loss in FY 2019) Jan 31 Think Research Corporation (TSXV:THNK) completed the acquisition of Clinic 360 for CAD 5.5 million.
Think Research Corporation (TSXV:THNK) acquired AirMed Trials Inc. for CAD 0.75 million. Jan 29
Think Research Corporation (TSXV:THNK) entered into a share purchase agreement to acquire mdBriefCase Inc. from PCP GP, L.P. ,Jason Flowerday and others for CAD 24.9 million Jan 20
Think Research Announces Appointment of Dr. Eric Hoskins to Board of Directors Jan 19
Think Research Corporation (TSXV:THNK) agreed to acquire Clinic 360 for CAD 5.8 million. Jan 05 Shareholder Returns THNK CA Healthcare Services CA Market 7D -3.1% -3.0% -2.6% 1Y -26.2% 121.4% 15.2%
See full shareholder returns
Return vs Market: THNK underperformed the Canadian Market which returned 3.6% over the past year.
Price Volatility Is THNK's price volatile compared to industry and market? THNK volatility THNK Average Weekly Movement 27.8% Healthcare Services Industry Average Movement 9.4% Market Average Movement 8.2% 10% most volatile stocks in CA Market 17.4% 10% least volatile stocks in CA Market 2.9%
Stable Share Price: THNK's share price has been volatile over the past 3 months.
Volatility Over Time: THNK's weekly volatility has increased from 19% to 28% over the past year.
About the Company Think Research Corporation provides knowledge-based digital health software solutions in Canada, the United States, and internationally. The company’s products portfolio comprises order sets that structures clinical pathway at the point of care; eReferrals that allows physicians to find and refer specialists directly from EMR systems; Digital Front Door, a patient engagement platform that enables healthcare organizations to provide access to care and health information through a single digital service window; VirtualCare, which allows clinicians and allied health professionals to replace in-person appointments with virtual visits; and eForms, a real-time analytics to track resident volumes, signature adherence, and compliance; and COVID-19 clinical tools, as well as clinical support tools for long-term care. Think Research Corporation is based in Toronto, Canada.
Show more Think Research Corporation Fundamentals Summary How do Think Research's earnings and revenue compare to its market cap? THNK fundamental statistics Market cap CA$24.56m Earnings (TTM ) -CA$15.33m Revenue (TTM ) CA$85.10m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) THNK income statement (TTM ) Revenue CA$85.10m Cost of Revenue CA$43.12m Gross Profit CA$41.98m Other Expenses CA$57.31m Earnings -CA$15.33m
Last Reported Earnings
Sep 30, 2023
Earnings per share (EPS) -0.19 Gross Margin 49.33% Net Profit Margin -18.02% Debt/Equity Ratio 149.2%
How did THNK perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/04/18 04:53 End of Day Share Price 2024/04/18 00:00 Earnings 2023/09/30 Annual Earnings 2022/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Think Research Corporation is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Douglas Taylor Canaccord Genuity Gavin Fairweather Cormark Securities Inc. David Newman Desjardins Securities Inc.
Show 2 more analysts 
